{"id":65685,"date":"2025-03-17T00:01:50","date_gmt":"2025-03-17T00:01:50","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/03\/17\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/"},"modified":"2025-03-17T00:01:50","modified_gmt":"2025-03-17T00:01:50","slug":"global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/","title":{"rendered":"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites"},"content":{"rendered":"<div>\n<p><img loading=\"lazy\" decoding=\"async\" alt=\"Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites\" data-mce-style=\"display: block; margin-left: auto; margin-right: auto;\" height=\"408\" name=\"GNW_RichHtml_External_IMG\" src=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/62760c7f-8f99-4ca4-ba9d-a433074a6505\/taiwan-mous.png\" style=\"display:block; margin-left:auto; margin-right:auto;\" width=\"600\"><\/p>\n<p>TAIPEI, Taiwan and ADELAIDE, Australia, March  17, 2025  (GLOBE NEWSWIRE) &#8212; Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, is pleased to announce the signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan this week. These new partnerships mark a strategic expansion into Taiwan, reinforcing Avance Clinical\u2019s commitment to providing US biotechs with access to high-quality clinical research solutions across the Asia-Pacific region.<\/p>\n<p><strong>Avance Clinical CEO<\/strong> <strong>Yvonne Lungershausen<\/strong> emphasized the importance of these new partnerships and highlighted the value of being personally present at the MOU signing to connect with the exceptional teams at these centers. She stated, \u201cExpanding into Taiwan marks another key milestone for Avance Clinical as we continue to expand our global network across Asia.\u201d<\/p>\n<p>Avance Clinical\u2019s <strong>Vice President, Global Project Delivery,<\/strong> <strong>Joe Taouk<\/strong>, emphasized the significance of this expansion: \u201cTaiwan is recognized for its advanced healthcare infrastructure, highly skilled research teams, and regulatory efficiency, making it an attractive destination for clinical trials. By partnering with these leading Taiwanese institutions, we are further strengthening our ability to support biotech sponsors in executing high-quality, efficient clinical trials with access to diverse patient populations.\u201d<\/p>\n<p><strong>Kelly Yang, Associate Director, Taiwan Operations,<\/strong> highlighted the benefits for biotechs looking to expand into Taiwan: \u201cOur partnerships with these respected institutions will provide biotech sponsors with streamlined access to Taiwan\u2019s high-quality clinical trial ecosystem. The country\u2019s efficient regulatory pathways, combined with these hospitals\u2019 deep expertise, will enable our clients to accelerate the development of their therapies while maintaining the highest scientific and ethical standards.\u201d<\/p>\n<p>The MOUs are set to be signed this week with:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt;\"><strong>Taichung Veterans General Hospital (TCVGH)<\/strong>: Professor Yun-Ching Fu, the Dean of TCVGH said, \u201cTaichung Veterans General Hospital has deeply committed to clinical research across various study phases as well as the innovative treatments, with extensive experience in clinical trials and professional capabilities in regenerative medicines. TCVGH is a leader in advanced CAR-T cell immunotherapy, ranking the second in Taiwan for the number of treated cases and achieving a 100% of cure rate. \u201cThis partnership will accelerate the development of cancer treatments and other groundbreaking therapies, bringing life-changing benefits to patients worldwide.\u201d<\/li>\n<li style=\"margin-bottom:8pt;\"><strong>Taipei Medical University (TMU)<\/strong>: \u201cWe are excited to collaborate with Avance Clinical to advance clinical research and bring new treatment opportunities to patients. This partnership enhances our medical centers\u2019 ability to make a significant impact, strengthens our presence in global trials, and ultimately improves healthcare through innovation,\u201d said Professor Chun-Che Shih, Executive Vice President of Taipei Medical University.<\/li>\n<li style=\"margin-bottom:8pt;\"><strong>China Medical University Hospital (CMUH)<\/strong>: Professor Der-Yang Cho, Dean of CMUH, emphasized the significance of the partnership: \u201cWe are excited to collaborate with Avance Clinical to expand international research opportunities and further strengthen our capabilities in early-phase studies. This agreement not only enhances our ability to support global biotech companies but also accelerates the delivery of innovative treatments to patients.\u201d<\/li>\n<li style=\"margin-bottom:8pt;\"><strong>Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)<\/strong>: \u201cOur partnership with Avance Clinical is incredibly valuable to KMUH as it allows us to connect with innovative biotech companies from around the world and bring cutting-edge clinical trials to Taiwan,\u201d said Jaw-Yuan Wang, Superintendent of\u00a0Kaohsiung Medical University Chung-Ho Memorial Hospital. \u201cBy combining our clinical research expertise and diverse patient population with Avance Clinical\u2019s global trial management capabilities, we can accelerate the development of new therapies and provide our patients with earlier access to groundbreaking treatments.\u201d<\/li>\n<\/ul>\n<p>These agreements reinforce Avance Clinical\u2019s <strong>GlobalReady model<\/strong>, offering biotech companies a seamless pathway to leverage the region\u2019s clinical trial capabilities, regulatory efficiencies, and patient access.<\/p>\n<p><strong>About Avance Clinical<\/strong><\/p>\n<p>Avance Clinical is a leading Contract Research Organization (CRO) offering biotech companies faster, more flexible, and higher-quality clinical trial services. As the largest premium full-service CRO headquartered in Australia, Avance Clinical delivers globally accepted data across Australia, New Zealand, Asia, North America, and Europe for international biotechs. With 30 years of experience and expertise spanning over 250 indications, the company provides comprehensive clinical research services from early to late-phase trials.<\/p>\n<p><strong>For more information, visit <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=17bLpNMY8tSVXvoiBvFZhq3VVDLDVS8JXIbPjiSP7-8lU-kENvP42PCYX0VMRGPZRz4KLMCZUd7G0gspbfINK3BAGM1hsAADOBRmPrmoe4c=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>www.avancecro.com<\/strong><\/a><\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt;\">Discover Avance Clinical\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PdnLyVLe-tIdO16tK-w7OWQlFCWCB805B2yQz2sj_noB7dhhKCGRquRyE6e5vneP6ioHnx4SCc2atnh1R59x4fwzDhDALMnooHXm1QKsmNG_H274-dt9RF53FbCBT1uf-UiUhzKWAKloKKMYE_dYsw==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>Asia Advantage<\/strong><\/a><\/li>\n<li style=\"margin-bottom:8pt;\">Get into clinic faster with Avance Clinical\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PdnLyVLe-tIdO16tK-w7OcmPo3ZmoCtj_tP0w4PCeyqLhlc_azbcdA-FmN-IAjvY-CiyhGpsYPI07gga883t-U7FGctOQQ_Jg4uS-iLKz1636PPWdrc_T39agxGHQr2gzYXpu5-_gRPsY6qdK3rKHw==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>ClinicReady<\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PdnLyVLe-tIdO16tK-w7OTe8q6A45xHiSTw04Y9y7gagMnASQI2Ce6Oz9q8yuLhs2Gti76Vu1FYs5r4E2VU5HHW0mqX-HukX5f3k3f4jiRId5oCZmTp4wn7ai6Ob6P4XJHJDBxf1rKEIZ823L359fw==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong> service<\/strong><\/a><\/li>\n<li style=\"margin-bottom:8pt;\">Learn about Avance Clinical\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PdnLyVLe-tIdO16tK-w7OYmlxAoLkKM-Uel7xWywuy470kn85UyJXmhJYg7NvHMUChATB8x0i2dsip97KK8PuWLZvn07Go3YbzbNuM8kwF9K0uVR-PGlVPsWOqTubi1C\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>GlobalReady<\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PdnLyVLe-tIdO16tK-w7Oagx4fKGb0wiX5agt3M508b0WY9kh5EkLQaDFXzdy2GPcyjacMKtlS_bqfEJdshX15tDtzxJL_UJZJ0JUPKkN61WtboVfNxOLUCqfG0_u8Va\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong> model<\/strong><\/a> for biotechs<\/li>\n<li style=\"margin-bottom:8pt;\">Speak with our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PdnLyVLe-tIdO16tK-w7OSOC5x7IWz9dTJduoj0mnxiNt0Xp43K8CbiZdZQCushWvhzTBDGwEeyEjCVbh5isEo5idfHl1nCEF-RQd64TbyZJTzo5Z3VaEPKaPA46y3aW8TngybN7kByUE21RLRBY1w==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>clinical trial experts<\/strong><\/a> about your upcoming study<\/li>\n<li style=\"margin-bottom:8pt;\">Book a meeting or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZHPWRLrayHQH5KPaVO2YVKXXutFq0ASQhzkYwJ7Hx72FHE71qE5HD6LdPIoX5bYZaPQGcvoitoCoCvetR59sm3gMBPpNjU5SI2mQvtLlCb8l3w7sxMOH3WPq3xpPXdDU\" rel=\"nofollow\" target=\"_blank\" title=\"request a proposal\">request a proposal<\/a><\/li>\n<\/ul>\n<p><strong>Media Contact:<\/strong><br \/>Avance Clinical<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5SfttEJ8IuEjDyOwr5mKj9HOnjU0q744qNd4S0t_mr9a9o5IilHgkl9X4c3HgW9Ju9qetXn19i5siNCU2ATVw0hkHMOmyVODZjhHPITQ6SM=\" rel=\"nofollow\" target=\"_blank\" title=\"media@avancecro.com\">media@avancecro.com<\/a><\/p>\n<p>A photo accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kz7CdQueFpSCgmbhtY9fCpZvJQ3geAQXBBDwJ_t7v43VeK0UIqzdpkDs2VJbNZkG94Uad8U64f6IRxlmsMbgElMDGJvUB0z1kg6uTW5tQqFghwubBks6OQ7U9QvctlIUNs-GYznecfV7gVcQ4MfRM5EyZQI3edPSxKTnUdKFDcOpS8eHHTmyS1BYD_gngkiLlxtIMbc1Uf8xY9nn4uAFiwIX940UXGHXkUOwfLcjPx_DmDcuFUxeoVflzOdMRTPGru-h3-WSKs7XGA-r38VBcg==\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/62760c7f-8f99-4ca4-ba9d-a433074a6505<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTIzODk0ZDgtODU2NS00N2IyLWI4ODMtYWUwZTEwZGQ1ZmJhLTEyNDUwNzUtMjAyNS0wMy0xNi1lbg==\/tiny\/Avance-Clinical.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TAIPEI, Taiwan and ADELAIDE, Australia, March 17, 2025 (GLOBE NEWSWIRE) &#8212; Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, is pleased to announce the signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan this week. These new partnerships mark a [&#8230;]\n","protected":false},"author":1,"featured_media":65686,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-65685","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites\" \/>\n<meta property=\"og:description\" content=\"TAIPEI, Taiwan and ADELAIDE, Australia, March 17, 2025 (GLOBE NEWSWIRE) &#8212; Avance Clinical, a leading full-service global Contract Research Organ\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-17T00:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/03\/taiwan-mous.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"815\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites\",\"datePublished\":\"2025-03-17T00:01:50+00:00\",\"dateModified\":\"2025-03-17T00:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/\"},\"wordCount\":761,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/\",\"name\":\"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-03-17T00:01:50+00:00\",\"dateModified\":\"2025-03-17T00:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/","og_locale":"en_US","og_type":"article","og_title":"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites","og_description":"TAIPEI, Taiwan and ADELAIDE, Australia, March 17, 2025 (GLOBE NEWSWIRE) &#8212; Avance Clinical, a leading full-service global Contract Research Organ","og_url":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-03-17T00:01:50+00:00","og_image":[{"width":1200,"height":815,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/03\/taiwan-mous.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites","datePublished":"2025-03-17T00:01:50+00:00","dateModified":"2025-03-17T00:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/"},"wordCount":761,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/","url":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/","name":"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-03-17T00:01:50+00:00","dateModified":"2025-03-17T00:01:50+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/global-reach-for-us-biotechs-avance-clinical-secures-mous-with-four-premier-taiwanese-trial-sites\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/65685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=65685"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/65685\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/65686"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=65685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=65685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=65685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}